Table 1. CD3⁺-positive cells in PBMC from 13 patients with melanoma.

#	Age	Sex	Stage	Status	Primary site	Most recent tumor	CD3+ in PBMC (%)	CD4+ in CD3 (%)	CD8+ in CD3 (%)
1	68	F	IA	AWD	Extremity	Leg	38.28	77.37	20.87
2	64	M	IA	AWD	Head and Neck	Face	37.1	55.47	34.5
3	50	M	IB	AWD	Head and Neck	Ear	35.28	74.41	20.81
4	47	M	IIB	AWD	Trunk	Back	35.38	67.72	30.73
5	45	M	III	AWD	Head and Neck	oral cavity	47.97	53.55	35.96
6	54	M	IIIB	AWD	Head and Neck	Head	40.7	82.41	10.96
7	77	M	IIIB	NED	Head and Neck	Lymph node	19.94	37.96	59.58
8	63	M	IV	AWD	Head and Neck	Head	18.61	51.74	43.33
9	61	F	IV	AWD	Head and Neck	Ear	22.68	82.63	14.99
10	56	F	IV	AWD	not available	Lung/chest wall	11.11	58.15	38.33
11	70	M	IV	NED	Trunk	Back	15.58	83.83	5.91
12	32	F	IV	NED	Head and Neck	Liver	19.39	61.17	37.26
13	44	M	IV	NED	Head and Neck	Lung/chest wall	35.17	63.72	33.52

AWD: alive with disease

NED: no evidence of disease